Inventor

WHALLEY BENJAMIN

GB20 patents

⚠️ This page may combine multiple inventors who share the name “WHALLEY BENJAMIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

WHALLEY BENJAMIN

GW RES LTD

Cannabidiol preparations and its uses

Use of cannabinoids in the treatment of epilepsy

Use of cannabinoids in the treatment of epilepsy

7-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in the treatment of epilepsy

Cannabidiol-type cannabinoid compound

7-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in the treatment of epilepsy

Cannabidiol preparations and its uses

Use of cannabidiol in combination with 5-HT2B receptor agonists or amphetamines in the treatment of epilepsy

Use of cannabinoids in the treatment of a neurodegenerative disease or disorder

JAZZ PHARMACEUTICALS RESEARCH UK LTD

Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy

Use of cannabidiol in the treatment of tuberous sclerosis complex

Cannabidiol-type cannabinoid compound

Cannabidiol-type cannabinoid compound

Cannabidiol-type cannabinoid compound

Cannabinoid derivatives as pharmaceutically active compounds and methods of preparation thereof

Use of cannabinoids in the treatment of dyskinesia associated with parkinson&#39;s disease

GW PHARMA LTD

Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy

Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)

Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)

WHALLEY BENJAMIN

Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)

Use of cannabinoids in the treatment of dyskinesia associated with parkinson's disease